Increase of 1,25 dihydroxyvitamin D in sarcoidosis patients with renal dysfunction

Tebben PJ, Singh RJ, Kumar R. Vitamin D-mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr Rev. 2016;37(5):521–47.

Wolf M. Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol. 2010;21(9):1427–35.

Nakano C, Hamano T, Fujii N, et al. Combined use of vitamin D status and FGF23 for risk stratification of renal outcome. Clin J Am Soc Nephrol. 2012;7(5):810–9.

Lips P. Relative value of 25(OH)D and 1,25(OH)2D measurements. J Bone Miner Res. 2007;22(11):1668–711.

Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153–65.

Huart A, Kamar N, Lanau JM, Dahmani A, Durand D, Rostaing L. Sarcoidosis-related hypercalcemia in 3 chronic hemodialysis patients. Clin Nephrol. 2006;65(6):449–52.

Arai Y, Tanaka H, Hirasawa S, et al. Sarcoidosis in a chronic dialysis patient diagnosed by sarcoidosis-related hypercalcemia with no common systemic clinical manifestations: a case report and review of the literature. Intern Med. 2013;52(23):2639–44.

Berlin JL, Shantha GPS, Yeager H, Thomas-Hemak L. Serum vitamin D levels may not reflect tissue-level vitamin D in sarcoidosis. BMJ Case Rep. 2014;2014:bcr2014203759. https://doi.org/10.1136/bcr-2014-203759 .

Loffler C, Loffler U, Tuleweit A, et al. Renal sarcoidosis: epidemiological and follow-up data in a cohort of 27 patients. Sarcoidosis Vasc Diffus Lung Dis. 2015;31(4):306–15.

Mahevas M, Lescure FX, Boffa JJ, et al. Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore). 2009;88(2):98–106.

Fogo AB, Lusco MA, Najafian B, et al. AJKD Atlas of renal pathology: sarcoidosis. Am J Kidney Dis. 2016;68(1):e5–e6.

Baughman RP, Janovcik J, Ray M, et al. Calcium and vitamin D metabolism in sarcoidosis. Sarcoidosis Vasc Diffus Lung Dis. 2013;30(2):113–20.

Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2):736–55.

Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92.

Hiramatsu R, Hoshino J, Suwabe T, et al. Membranoproliferative glomerulonephritis and circulating cryoglobulins. Clin Exp Nephrol. 2014;18(1):88–94.

Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013;48(3):452–8.